Ropes & Gray advised global private investment firm TPG on its acquisition from Actavis plc of Actavis’ Aptalis Pharmaceutical Technologies (Pharmatech) business. Pharmatech is a leader in pharmaceutical research and development and manufacturing, with a focus on areas including taste-masking and customized drug release. The deal was announced Feb. 13; financial terms were not disclosed.
The Ropes & Gray team was led by private equity partner Jason Freedman (San Francisco) and tax partner David Saltzman (Boston).
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.